ResearcherSemmelweis UniversityActive in the last 2 years

Krisztina Andrea Szigeti

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5074995255. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-34204-y ↗
Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer. Co-author DOI 10.3389/pore.2024.1611948 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

József Tı́már · 2 shared papers, 2024–2026 · strength 0.54
- Paper Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenoc… DOI 10.1038/s41598-025-34204-y ↗
- Paper Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreati… DOI 10.3389/pore.2024.1611948 ↗
Eszter Molnár · 1 shared paper, 2024 · strength 0.21
- Paper Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreati… DOI 10.3389/pore.2024.1611948 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.